V-Myc骨髓细胞瘤病毒癌基因同源物(MYC)活性蛋白

Active V-Myc Myelocytomatosis Viral Oncogene Homolog (MYC)

C-Myc; BHLHE39; Myc Proto-Oncogene Protein; VMyc Class E basic helix-loop-helix protein 39; Transcription factor p64; Proto-oncogene c-Myc

  • V-Myc骨髓细胞瘤病毒癌基因同源物(MYC)活性蛋白产品包装(模拟)
  • V-Myc骨髓细胞瘤病毒癌基因同源物(MYC)活性蛋白产品包装(模拟)
  • V-Myc骨髓细胞瘤病毒癌基因同源物(MYC)活性蛋白Gene sequencing
  • APB290Hu01.jpgFigure. SDS-PAGE
  • V-Myc骨髓细胞瘤病毒癌基因同源物(MYC)活性蛋白Figure. Western Blot; Sample: Recombinant MYC, Human.
  • Certificate通过ISO 9001、ISO 13485质量体系认证

活性实验

MYC (Myc proto-oncogene protein) is a nuclear phosphoprotein that binds specific sequence of DNA. MYC functions as a transcription factor and regulates transcription of target genes. It has been proven that c-Myc protein is intracellularly associated with TBP (TATA-binding protein) of the TFIID transcription initiation complex; besides, TRRAP (Transformation/transcription domain-associated protein) is thought to be an essential cofactor for the MYC. Thus a binding ELISA assay was conducted to detect the interaction of MYC with TBP and TRRAP. Briefly, recombinant human MYC were diluted serially in PBS, with 0.01%BSA (pH 7.4). Duplicate samples of 100uL were then transferred to TBP-coated and TRRAP microtiter wells and incubated for 2h at 37°C. Wells were washed with PBST and incubated for 1h with anti-MYC pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37°C. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of MYC with TBP and TRRAP was shown in Figure 1 and Figure 2 separately, and this effect was in a dose dependent manner.

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。